Board Members
Global Virus Network (GVN) Announces Seven Distinguished International Appointments to Board of Directors
World Leaders In Academia, Business, Government, Healthcare, Philanthropy & Science Commit Their Expertise To Advancing The Development & Expansion Of The GVN Baltimore, MD, USA (May 3, 2022) – The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from viral disease, today announced…
Read MoreGlobal Virus Network (GVN) Adds Senegal’s IRESSEF As Newest Member to Mitigate Viral Threats
Baltimore, Maryland, USA, July 15, 2021: The Global Virus Network (GVN), representing 63 Centers of Excellence and 11 Affiliates in 35 countries comprising foremost experts in every class of virus causing disease in humans, and the Institut de Recherche en SantĂ©, de Surveillance EpidĂ©miologique et de Formation , or the IRESSEF, announced the addition of…
Read MoreA Media Briefing Addressing the Exploding International COVID-19 Crisis: Global Virus Network – Ideas For a Global Vaccination Strategy
June 30, 2021 Drs. Robert Gallo, Christian BrĂ©chot, Sharon Lewin, and Amadou Sall Global Vaccination Vaccination is one of the most effective control measures for human infectious diseases. COVID-19 vaccines, particularly mRNA vaccines, have been very effective, including against the current SARS-CoV-2 variants. Thus, successful vaccination has resulted in mitigating SARS-CoV-2 infection in countries, such…
Read MoreGlobal Virus Network (GVN) Adds Gilead Sciences to GVN Healthcare & Pharma Centers of Excellence Coalition
The Partnership Focuses on Stimulating Collaborations and Training the Next Generation of Virus Researchers to Prepare for and Mitigate Future Global Threats Baltimore, Maryland, USA, June 30, 2021: The Global Virus Network (“GVN”), the world’s leading coalition of virologists combatting current and emerging pandemic viral threats and viral causes of disease through international collaborative research…
Read MoreCeldara Medical and Global Virus Network Announce Collaboration to Advance Infectious Disease and Viral Infection Research and Development
The partnership will initially focus on SARS-CoV-2 and future pandemic threats. BALTIMORE, MD and CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, June 2, 2021 — Celdara Medical, LLC (Celdara), an experienced biopharma developer focused on launching promising products to the patients who need them the most, today announced a new strategic collaboration with the…
Read MoreGlobal Virus Network Analysis Suggests Measles, Polio and Tuberculosis Vaccines May Boost Immunity to Coronavirus
Innate Immunity Created by Live Attenuated Vaccines Like Measles and Polio May Provide Some Protection Against Future Pandemics – Idea Needs To Be Tested, Scientists Say BALTIMORE, MD, May 18, 2021: Members of the Global Virus Network (GVN), a coalition comprised of human and animal virologists from 63 Centers of Excellence and 11 Affiliates in…
Read MoreGlobal Virus Network (GVN) Announces Eight Distinguished International Appointments to Board of Directors
World Leaders in Business, Science, Law, Industry, Philanthropy & Government Are Committed to Supporting the GVN Baltimore, MD, USA (April 6, 2021) – The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from viral disease, today announced the election of eight distinguished…
Read MoreINTERNATIONALLY RENOWNED VIROLOGIST CHRISTIAN BRÉCHOT APPOINTED PRESIDENT OF THE GLOBAL VIRUS NETWORK (GVN)
Brings Decades of Scientific & Organizational Leadership To Advance GVN’s Mission Melbourne, Australia, September 25, 2017: The Global Virus Network (GVN), an international coalition of the world’s foremost medical virologists, comprising 40 Centers of Excellence in 24 countries, dedicated to identifying and researching, combatting and preventing, current and emerging pandemic viruses that pose a critical…
Read MoreProminent Virologist Stanley Plotkin Joins GVN as Senior Advisor
Baltimore, MD: January 14, 2014 ;The Global Virus Network (GVN) is honored to have Dr. Stanley A. Plotkin, Emeritus Professor of the University of Pennsylvania and consultant to all of the major vaccine manufacturers, serve as a senior advisor. Dr. Plotkin is world renowned for his development of the rubella vaccine- now in standard use throughout the world,…
Read MoreGallo reflects on 30 years in HIV research
Gallo reflects on 30 years in HIV research Dan Rodricks, of the Baltimore Sun in January 4 th interview of Dr. Robert Gallo, and discusses the current advances leading to a “functional cure” .
Read More